PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2021

Jun 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2021-06-17

Reporting Person: Wong Alvin F (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-17	STOCK OPTION (RIGHT TO BUY)	$10.21	A	90000	Acquired	2031-06-16	COMMON STOCK (90000)	Direct

Footnotes

F1: Subject to the Reporting Person's continued employment with the Company through the applicable vesting date, 1/3rd of the shares underlying the option will vest on the first anniversary of June 15, 2021 (the "Option Vesting Commencement Date"), and 1/36th of the shares underlying the option will vest on each monthly anniversary of the Option Vesting Commencement Date thereafter.